logo
What's your investment psychology?

What's your investment psychology?

Fast Company11-07-2025
Douglas Adams' brilliant novel The Restaurant at the End of the Universe describes Milliways, the fine dining establishment built in a time bubble and projected forward to the precise moment of the End of the Universe. Meals at such a singular restaurant are ridiculously expensive–but diners can easily pay for them.
'All you have to do is deposit one penny in a savings account in your own era, and when you arrive at the End of Time, the operation of compound interest means that the fabulous cost of your meal has been paid for,' Adams wrote.
When I read this novel as an impressionable 12-year-old, the Milliways-approved investing process appealed to me. With a little bit of money and a whole lot of time, compound interest could do the work for me while I sat back and looked forward to a truly world-shattering meal.
I was reminded of this recently when my spouse asked if the investment decisions we had set-and-forget several years before were maximizing our returns. Instead of jumping at the chance to ensure our finances were living up to their potential, I was annoyed at the prospect of having to make changes to a system I'd already set up.
Until that moment, I thought I had a handle on my financial psychology. But apparently, I have some quirks of investment psychology that I wasn't even aware of. As do you.
Here's how your investment psychology may be misdirecting your investing decisions—and what you can do to get back on track.
What is investment psychology?
Although we think of finance and investing as a 'rational' activity, we are likely to react emotionally to money. This is partially because of mental shortcuts known as cognitive biases. These are systematic patterns in thinking that can lead us to irrational decisions or behavior that runs counter to our goals.
For example, my preference to set-and-forget my investments is partially due to a cognitive bias known as the status quo bias. This cognitive bias describes a preference for the current state of affairs to remain the same.
I don't like to think of myself as a stick in the mud, and I could have given my spouse a rational-sounding reason why I don't double check that our investments are maximized. But I can see that my lack of interest in revisiting old decisions reflects something about my investing psychology: I prefer to make a decision once and stick to it. That's the specific aspect of the status quo that I don't want to change.
This preference for once-and-done decision making isn't necessarily a bad thing, but it can cost me. If my spouse hadn't asked about our returns, I never would have thought to check and we could have lost years' worth of potential returns.
After this experience, my spouse and I have realized that he needs to occasionally nudge me to check back on old investing decisions. That will help me avoid the complacency of my status quo bias.
Common investment psychology biases
There are a number of cognitive biases that may be keeping your investments from growing. Which of these biases sound like you?
Action bias
The action bias could be seen as the opposite of the status quo bias. If you have this cognitive quirk, you will feel the need to do something– anything! –rather than nothing.
If your portfolio drops in value, your action bias might lead you to sell in order to avoid a larger loss. Unfortunately, taking action at that time is often the worst option, since most losses are temporary, and selling makes the loss permanent.
To avoid the action bias, commit to waiting 24 to 48 hours before taking any action with your portfolio. This will give the market some time to recover from momentary dips, and will not make a significant difference if action is called for.
Additionally, find a trusted adviser or friend who can help you determine when action or inaction is appropriate. This can help keep you from developing an itchy trading finger.
Disposition effect
This cognitive bias describes the phenomenon where investors tend to sell a winning investment too soon while holding onto a tanking investment for too long. When you are experiencing the disposition effect, which combines a fear of losing out (in case the tanking investment suddenly goes gangbusters) plus a fear of regret (in case the winning investment takes a dive), you are trying to hedge your losses in both directions.
But evidence has shown that selling the losing investment and holding onto the winning investment is the smarter strategy. The disposition effect is making an emotional decision to hedge loss, rather than a rational choice to try to maximize your returns.
Researchers have found the best way to avoid the disposition effect is to implement long-term investment goals. Investors with a clear financial target not only successfully avoid the disposition effect, but they exhibit a reversal of the effect, selling the losing investments and keeping the winners.
Familiarity bias
Also known as the mere exposure effect, this cognitive bias leads investors to overinvest in assets they are familiar with. Specifically, American investors are more likely to put their money in domestic stocks, bonds, and funds, rather than getting international exposure in their portfolio.
The familiarity bias can go even further, with investors buying shares of companies they recognize, or even the company that employs them. (You might remember that Lehman Brothers' employees owned 30% of the company's shares at the time of the bank's collapse.)
But just because an investor is familiar with an asset doesn't make it the right investment for their portfolio. Diversification is typically the best way of combatting the familiarity bias. This may require the help of a financial adviser if you don't feel comfortable picking diverse international investments or other assets outside of your sphere of exposure.
Don't panic: a rational guide to investing
Humans aren't great at making rational investment decisions, but we're very good at lying to ourselves about that fact. To improve your investment choices—not to mention your returns—start by recognizing the ways in which your investing psychology may be leading you astray.
Perhaps, like me, you suffer from the status quo bias, and prefer to avoid revisiting any decisions you've already made. Or you might experience the opposite quirk, the action bias, which tells you to do something! anytime there is the slightest movement in your portfolio. You may fall victim to the disposition effect, where you hold onto a stinker and sell a winner, despite it being a losing strategy. Or you might just stick with the familiar companies, asset classes, and investments you know, rather than diversifying your portfolio.
Here's the good news: once you know your brain is taking these shortcuts, you're better prepared to avoid them.
As for me, I'm still keeping my Milliways savings account open. I've got the time.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Warren Buffett's Berkshire Hathaway sold stocks and didn't snap up bargains even as markets crumbled after ‘Liberation Day'
Warren Buffett's Berkshire Hathaway sold stocks and didn't snap up bargains even as markets crumbled after ‘Liberation Day'

Yahoo

time34 minutes ago

  • Yahoo

Warren Buffett's Berkshire Hathaway sold stocks and didn't snap up bargains even as markets crumbled after ‘Liberation Day'

Berkshire Hathaway's second-quarter results showed that the conglomerate remained a net seller of stocks and continued to accumulate cash. That period includes the head-spinning stock market plunge and rebound following President Donald Trump's rollout of aggressive tariffs on 'Liberation Day' in April. Warren Buffett's Berkshire Hathaway largely remained on the sidelines last quarter, even as the stock market cratered on President Donald Trump's 'Liberation Day' tariffs and briefly presented steep bargains. Second-quarter results released on Saturday revealed that the conglomerate was a net seller of stocks for the 11th straight quarter. Berkshire offloaded $6.92 billion during the quarter and bought $3.9 billion. Meanwhile, Buffett's cash pile kept getting bigger, hitting a fresh high of $344 billion at the end of June, up from $333 billion at the end of March. Berkshire also refrained from stock repurchases for the fourth consecutive quarter. The legendary value-conscious investor has bemoaned the lack of good deals for years now. That includes possibilities for large acquisitions of companies that could be folded into Berkshire as well as major stock purchases for the portfolio. At the same time, Buffett has also avoided knee-jerk moves, and the stock market saw a head-spinning plunge and rebound in April as Trump shocked Wall Street with his aggressive tariffs then put them on hold just days later. During the selloff, the S&P 500 flirted with bear market territory, diving nearly 20% from its prior high. But the index has since shot back up to fresh records. Still, the swoon also highlighted Buffett's uncanny timing, as he appeared to anticipate a market downturn last year by selling $134 billion in equities in 2024—when the bull market was still raging. The stock market swings also came as Buffett was contemplating a transition away from his leadership role. In May, he announced that his anointed successor, Greg Abel, should take over as Berkshire Hathaway CEO by the of the year. While Buffett is expected to stay on as chairman, he may be staying away from dramatic moves to clear the decks for Abel, who had already been taking on a bigger leadership role before May. Despite his aversion for major purchases lately, Buffett's annual letter to shareholders in February reaffirmed his commitment to staying invested in stocks and companies, even as cash continued to mount. 'Berkshire shareholders can rest assured that we will forever deploy a substantial majority of their money in equities—mostly American equities although many of these will have international operations of significance,' he wrote. 'Berkshire will never prefer ownership of cash-equivalent assets over the ownership of good businesses, whether controlled or only partially owned.' Berkshire also reported that its operating earnings, which exclude the impact of its investments, fell 4% to $11.16 billion in the second quarter as insurance-underwriting results weakened. The company booked a $3.8 billion impairment on its Kraft Heinz stake as well, marking down its value to $8.4 billion. This story was originally featured on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Recursion Pharmaceuticals (RXRX) Price Surges 9% Over Past Month
Recursion Pharmaceuticals (RXRX) Price Surges 9% Over Past Month

Yahoo

timean hour ago

  • Yahoo

Recursion Pharmaceuticals (RXRX) Price Surges 9% Over Past Month

Recursion Pharmaceuticals experienced a price increase of 9% over the past month, positioning it against the backdrop of a broader market decline driven by geopolitical tensions and weak jobs data. Despite these broader market headwinds, which saw significant tech stock declines due to tariff concerns and disappointing economic indicators, Recursion managed to outperform. The company's stock movement appeared isolated from these wider trends, which implies internal factors or developments might have played a part, although specific catalysts weren't highlighted during this period. This performance is noteworthy given the current market's overall downward trend of 2.7%. We've identified 3 possible red flags for Recursion Pharmaceuticals (1 is potentially serious) that you should be aware of. AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. Recursion Pharmaceuticals' recent 9% monthly share price increase amidst broader market declines may suggest that internal developments, rather than external factors, are influencing investor sentiment. Over the past year, however, the company's total shareholder return was a decline of 19.09%, highlighting a contrast to the short-term positive movement. Comparatively, RXRX underperformed the US Biotechs industry, which saw an 8.4% decline over the same period, and also lagged behind the US market return of 17.7%. The heightened interest in the stock could be linked to enthusiasm around its AI-driven drug discovery programs, including REC-617 and REC-994 trials, which suggest potential future revenue growth. Yet, Recursion's lack of profitability and reliance on successful trial outcomes may introduce uncertainty into earnings forecasts. The company's expected revenue growth of 39.9% annually for the next three years could be influenced by the new developments and partnerships, possibly providing support to the optimistic forecasts. The current share price of US$5.68 remains below the consensus analyst price target of US$7.14, indicating a potential upside of 25.7%. This price target reflects expectations of significant future revenue and earnings improvements. However, analysts' forecasts include assumptions such as increased profit margins and successful translation of ongoing projects into commercial revenues, underscoring the importance of navigating the risks and uncertainties outlined in their analysis. Investors may need to weigh these factors carefully when considering the company's ability to meet future targets. Evaluate Recursion Pharmaceuticals' prospects by accessing our earnings growth report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include RXRX. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@

3 Top Stocks to Buy With $1,000 in August
3 Top Stocks to Buy With $1,000 in August

Yahoo

timean hour ago

  • Yahoo

3 Top Stocks to Buy With $1,000 in August

Key Points This tech leader is seeing growing demand for cloud services, yet its stock trades at just 14 times expected earnings. A well-known athleisure superstar looks like it's oversold, and value investors should take a look. This diversified apparel company could be at the start of a turnaround. 10 stocks we like better than Alibaba Group › The stock market has shown incredible resiliency in 2025. After shaking off the trade wars and uncertainty for the economy, the S&P 500 is sitting close to new all-time highs. As August, which is historically a weak month for the markets, approaches, there are solid companies trading at reasonable valuations that are worth buying. If you have $1,000 to commit to a long-term investment plan, read why three Motley Fool contributors like Alibaba (NYSE: BABA), Lululemon Athletica (NASDAQ: LULU), and VF Corp (NYSE: VFC) right now. An undervalued tech giant (Alibaba): Shares of Alibaba are starting to climb out of the slump they've been in for the past few years. This is a great time to consider starting an investment in the tech giant. An improving economy in China and strong demand for the company's cloud services are major catalysts that could potentially double the share price within five years. Alibaba's e-commerce marketplaces, Taobao and Tmall, are posting steady growth in 2025. The March-ending quarter showed these businesses growing customer management revenue by 12% year over year. This primarily comes from fees charged to third-party merchants that sell goods on these marketplaces, which creates very profitable revenue streams for Alibaba. Alibaba has multiple levers to grow revenue in its e-commerce business. It credited recent growth from several initiatives, including the integration of its Cainiao logistics in its e-commerce business, in addition to new software service fees that helped capture a higher percentage of revenue from merchant activities. Another catalyst supporting the stock's recovery is strong growth in Alibaba Cloud. Enterprises are adopting artificial intelligence (AI) services at a rapid rate. Alibaba said its AI-related product revenue has grown at a triple-digit rate for seven consecutive quarters. Its investments in AI are positioning the company for strong growth over the next decade. Despite positive trends across the company, investors can buy shares at just 13.5 times this year's consensus earnings estimate -- a genuine bargain. The stock could double if investors pay a higher multiple of earnings that is consistent with the average S&P 500 price-to-earnings multiple of 30. Wall Street appears to be in the process of rerating Alibaba shares right now, making it a timely buy for the month of August. Too cheap to ignore Jennifer Saibil (Lululemon): Lululemon has been having a very tough time over the past few years, and its stock is down around 45% in 2025 alone. However, at the current price, it looks like the market is overselling it, and it's trading at a bargain price. After many years of strong growth, that growth has decelerated sharply. There are several factors working against it, including pressure in discretionary spending and increasing competition. Lululemon helped create the athleisure movement, but there are low barriers to entry in its industry. In fact, in the premium athleisure space, customers are often looking for the next important and exclusive brand. On top of that, there have been worries about how Lululemon will be affected by tariffs. It's no wonder investors have been losing enthusiasm for the stock. The 2025 fiscal first quarter (ended May 4) did little to quell the pessimism. Sales increased 7% year over year in the quarter, but comparable sales (comps) were up only 1%. Even worse, they decreased 2% in the Americas region. Management maintained its guidance for a mid-single-digit increase in revenue for the full year, but it revised its guidance down for full-year earnings per share (EPS). However, there's reason for optimism. Lululemon stock trades at a P/E ratio of only 14, and at this price, it looks like a good value. Lululemon is highly profitable with an operating margin of 18.5%. That was down 1.1 percentage points from last year in the first quarter, mostly due to tariffs. However, it's still industry-leading, way above similar athletic wear and regular apparel companies. The tariffs situation could be improving as the Trump administration continues to make deals with other countries. And in terms of other countries, although the Americas market has been disappointing, Lululemon is doing very well in China, where sales increased 22% over last year in Q1. At the current price, it could finally be time to give Lululemon stock another shot, especially if you're looking for a value stock. A turnaround is afoot at VF Corp. Jeremy Bowman (VF Corp): With the broad market at an all-time high, it may be a good time for investors to look to beaten-down stocks that could be undervalued. VF Corp. looks like one of those stocks right now. The apparel brand manager, which owns brands like Vans, The North Face, Timberland, and Dickies, has been one of the worst-performing apparel stocks in the market over the last five years. The stock is down about 85% from its peak in 2021. Weakness at Vans, a dividend cut, and broader headwinds on consumer discretionary products all weighed on the stock, but VF Corp. showed signs of a turnaround in the fiscal Q1 earnings report on Wednesday. While overall revenue was flat, the company delivered solid growth at all of its core brands except Vans, which is going through a "channel rationalization," meaning management is reducing the number of distribution points. However, Timberland was up 11%, and The North Face was up 6%. Vans, on the other hand, was down 14%, but the overall business is healthier than it might look. If management can stabilize Vans and improve profitability, the company should be on good footing. Its adjusted operating loss was much better than expected in Q1, and management's guidance calls for full-year growth in adjusted operating income and free cash flow. VF Corp. now trades at a price-to-sales ratio of just 0.5. That gives the stock upside potential if it can achieve a profit margin of just 5%, which would equal a price-to-earnings ratio of just 10 at the current P/S ratio. For a company with a set of well-known premium brands, that should be achievable. If the turnaround continues to make progress, VF could double or triple from here. Should you invest $1,000 in Alibaba Group right now? Before you buy stock in Alibaba Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Alibaba Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Jennifer Saibil has no position in any of the stocks mentioned. Jeremy Bowman has no position in any of the stocks mentioned. John Ballard has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Lululemon Athletica Inc. The Motley Fool recommends Alibaba Group. The Motley Fool has a disclosure policy. 3 Top Stocks to Buy With $1,000 in August was originally published by The Motley Fool

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store